Clinical trial
A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With…
NCT00002244 · OXO Chemie, Industry · Completed
Key facts
| NCT number | NCT00002244 |
|---|---|
| Title | A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pivotal Clinical Study Evaluating the Safety and Efficacy of WF10 (TCDO) Intravenous Solution in the Management of Patients With Late-Stage HIV Disease |
| Lead sponsor | OXO Chemie, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | WF10 |
| Enrollment | 240 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: